益气补脾凉血活血方治疗紫癜型肾炎临床观察被引量：1

Clinical Study of Yiqibupihuoxueliangxue Decoction on Purpura Nephritis

下载PDF

导出

摘要目的探讨益气补脾凉血活血中药汤剂治疗紫癜型肾炎的临床疗效。方法将92例紫癜肾炎患者随机分为治疗组52例和对照组40例,治疗组以益气补脾凉血活血中药汤剂加口服氯雷他定加静点复方甘草酸苷,对照组给予安慰剂加口服氯雷他定加静点复方甘草酸苷,两组均在治疗1周后评价临床疗效,治疗2周后分析尿常规及尿蛋白定量。结果治疗组的临床治愈率为84.62%,总有效率为98.08%,优于对照组的75.00%和90.00%,差异有统计学意义。治疗组降低血尿和蛋白尿时间短于对照组,差异有统计学意义。结论益气补脾凉血活血方在治疗紫癜型肾炎疗效显著,尚未出现不良反应。 Objective： To investigate the therapeutic effect of Yiqibupiliangxuehuoxue Decoction on purpura nephritis.Methods： 92 cases of purura nephritis patients were divided randomly into the treatment group and the control group.Besiding that the loratadine and the compound glycyrrhizin were used in 2 groups,the treatment group was treated with the Yiqibupiliangxuehuoxue Decoction and the control group was received the placebo.The clinical effects in 2 groups were observed after 1 week and the urine routine and the urine protine were detected after 2 weeks.Results： The clinical curative rate and total efficiency were 84.62% and 98.08% in the treatment group respectively.The related parameters were 75.00% and 90.00% in control group.Obviously,the clinical curative effect in treatment group was better than that in the control group.The treatment group costed less time to reduce hematuria and proteinuria.Conclusion： It is effective of Yiqibupiliangxuehuoxue Decoction on purpura nephritis.There was no adverse reaction in this therapy.

作者赵云霞李杨赵丽丽郭军英赵云夕

机构地区河北省赵县中医院河北省赵县人民医院河北省中医院

出处《中国中医急症》 2013年第6期965-967,共3页 Journal of Emergency in Traditional Chinese Medicine

基金河北省石家庄市科技局科技支撑计划项目(121461923)

关键词益气补脾凉血活血紫癜型肾炎 Yiqibupiliangxuehuoxue Decoction Purpura nephritis

分类号 R692.3 [医药卫生—泌尿科学]

引文网络
相关文献

参考文献4

1陈灝珠,林果为.实用内科学[M].12版.北京:人民卫生出版社,2005:2588.
2中华医学会儿科学分会肾脏病学组,姚勇,杨霁云,陈述枚,丁洁.小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志,2001,39(12):746-749. 被引量：1533
3吴玉斌.过敏性紫癜性肾炎的治疗进展[J].中国实用儿科杂志,2006,21(6):411-413. 被引量：69
4徐秀芹,刘春霞,权学莲,许鸿雁.中西医结合治疗过敏性紫癜性肾炎42例疗效观察[J].浙江中医杂志,2007,42(11):638-639. 被引量：13

二级参考文献23

1庞晓英,高继宁.孙郁芝教授治疗过敏性紫癜性肾炎的临证经验[J].中国中西医结合肾病杂志,2005,6(8):491-492. 被引量：13
2Mollica F,Li VS,Carozzo R,et al.Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura[J].Eur J Pediatr,1992,151 (2):140-144.
3Saulsbury FT.Corticosteroid therapy does not prevent nephritis in Henoch-Schonlein purpura[J].Pediatr Nephrol,1993,7 (1):69-71.
4Kawasaki Y,Suzuki J,Suzuki H.Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis:a clinical and histopathological study[J].Nephrol Dial Transplant,2004,19(4):858-864.
5Tanaka H,Suzuki K,Nakahata T,et al.Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis[J].Pediatr Nephrol,2003,18 (4):347-350.
6Shin JL,Park JM,Shin YH,et al.Can azathioprine and steroids alter the progression of severe Henoch-Schonlein nephritis in children?[J].Pediatr Nephrol,2005,20 (8):1087-1092.
7Kano K,Kyo K,Yamada Y,et al.Comparison between pre-and post-treatment clinical and renal biopsies in children receiving low dose cyclosporin-A for 2 years for steroid-dependent nephrotic syndrome[J].Clin Nephrol,1999,52 (1):19-24.
8Hino S,Takemura T,Okada M,et al.Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporin[J].Am J Kidney Dis,1998,31 (6):932-939.
9Shin JI,Park JM,Shin YH,et al.Henoch-Schonlein purpura nephritis with nephrotic-range proteinuria:histological regression possibly associated with cyclosporin A and steroid treatment[J].Scand J Rheumatol,2005,34 (5):392 -395.
10Ronkainen J,Autio-Harmainen H,Nuutinen M.Cyclosporin A for the treatment of severe Henoch-Schonlein glomerulonephritis[J].Pediatr Nephrol,2003,18 (11):1138-1142.